FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $766,391 | +48375.1% | 86,794 | -54.3% | 0.00% | -100.0% |
| Q1 2023 | $1,581 | +29.4% | 189,998 | +49.3% | 0.00% | 0.0% |
| Q4 2022 | $1,222 | -99.9% | 127,289 | -48.9% | 0.00% | 0.0% |
| Q3 2022 | $2,020,000 | +50.6% | 249,337 | +5.0% | 0.00% | 0.0% |
| Q2 2022 | $1,341,000 | -5.2% | 237,392 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $1,415,000 | +24.8% | 252,679 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $1,134,000 | -53.3% | 257,617 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,427,000 | -17.8% | 257,621 | -36.4% | 0.00% | -50.0% |
| Q2 2021 | $2,951,000 | +2488.6% | 404,772 | +2010.4% | 0.00% | – |
| Q1 2020 | $114,000 | -40.3% | 19,180 | -59.7% | 0.00% | – |
| Q2 2019 | $191,000 | -82.9% | 47,634 | -48.6% | 0.00% | -100.0% |
| Q1 2018 | $1,120,000 | – | 92,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |